J. R. Riordan, J. M. Rommens, B. Kerem, N. Alon, R. Rozmahel et al., Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA, Science, vol.245, pp.1066-1073, 1989.

C. E. Bear, C. H. Li, N. Kartner, R. J. Bridges, T. J. Jensen et al., Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR), Cell, vol.68, pp.809-818, 1992.

T. C. Hwang and D. N. Sheppard, Gating of the CFTR Cl ? channel by ATP-driven nucleotide-binding domain dimerisation, J Physiol, vol.587, pp.2151-2161, 2009.

L. S. Ostedgaard, C. S. Rogers, Q. Dong, C. O. Randak, D. W. Vermeer et al., Processing and function of CFTR-?F508 are species-dependent, Proc Natl Acad Sci, vol.104, pp.15370-15375, 2007.

H. Miki, Z. Zhou, M. Li, T. C. Hwang, and S. G. Bompadre, Potentiation of disease-associated cystic fibrosis transmembrane conductance regulator mutants by hydrolyzable ATP analogs, J Biol Chem, vol.285, 2010.

P. Vergani, S. W. Lockless, A. C. Nairn, and D. C. Gadsby, CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains, Nature, vol.433, pp.876-880, 2005.

R. C. Rubenstein, M. E. Egan, and P. L. Zeitlin, In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR, J. Clin. Invest, vol.100, pp.2457-2465, 1997.

C. R. Brown, L. Q. Hong-brown, J. Biwersi, A. S. Verkman, and W. J. Welch, Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein, Cell Stress Chaperones, vol.1, pp.117-125, 1996.

G. M. Denning, M. P. Anderson, J. F. Amara, J. Marshall, A. E. Smith et al., Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive, Nature, vol.358, pp.761-764, 1992.

C. Norez, S. Noel, M. Wilke, M. Bijvelds, H. Jorna et al., Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells by the alpha-glucosidase inhibitor miglustat, FEBS Lett, vol.580, pp.2081-2086, 2006.

Y. Wang, M. C. Bartlett, T. W. Loo, and D. M. Clarke, Specific rescue of cystic fibrosis transmembrane conductance regulator processing mutants using pharmacological chaperones, Mol. Pharmacol, vol.70, pp.297-302, 2006.

Y. Wang, T. W. Loo, M. C. Bartlett, and D. M. Clarke, Correctors promote maturation of cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by binding to the protein, J. Biol. Chem, vol.282, pp.33247-33251, 2007.

F. Becq, Y. Mettey, M. A. Gray, L. J. Galietta, R. L. Dormer et al., Development of substituted Benzo [c]quinolizinium compounds as novel activators of the cystic fibrosis chloride channel, J. Biol. Chem, vol.274, pp.27415-27425, 1999.

P. Trouvé, L. Drévo, M. A. Kerbiriou, M. Fichou, Y. Gillet et al., Annexin V is directly involved in cystic fibrosis transmembrane conductance regulator's chloride channel function, Biochim Biophys Acta, vol.1772, pp.1121-1133, 2007.

L. Drévo, M. A. Benz, N. Kerbiriou, M. Gioux, M. Pennec et al., Annexin A5 increases the cell surface expression and the chloride channel function of the ?F508-Cystic Fibrosis Transmembrane Regulator, Biochim Biophys Acta, vol.1782, pp.605-614, 2008.

F. Huguet, M. L. Calvez, N. Benz, L. Hir, S. Mignen et al., Function and regulation of TRPM7, as well as intracellular magnesium content, are altered in cells expressing ?F508-CFTR and G551D-CFTR, Cellular and Molecular Life Sciences, vol.73, issue.17, pp.3351-73, 2016.

J. Zielenski and L. C. Tsui, Cystic fibrosis: genotypic and phenotypic variations, Annu Rev Genet, vol.29, pp.777-807, 1995.

S. H. Cheng, R. J. Gregory, J. Marshall, S. Paul, and D. W. Souza, Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis, Cell, vol.63, pp.827-834, 1990.

S. Sato, C. L. Ward, M. E. Krouse, J. J. Wine, and R. R. Kopito, Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation, J Biol Chem, vol.271, pp.635-638, 1996.

M. J. Welsh, G. M. Denning, L. S. Ostedgaard, and M. P. Anderson, Dysfunction of CFTR bearing the delta F508 mutation, J Cell Sci, vol.17, pp.235-239, 1993.

W. Dalemans, P. Barbry, G. Champigny, S. Jallat, and K. Dott, Altered chloride ion channel kinetics associated with the DF508 cystic fibrosis mutation, Nature, vol.354, pp.526-528, 1991.

G. L. Lukacs, X. B. Chang, C. Bear, N. Kartner, and M. A. , The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells, J Biol Chem, vol.268, pp.21592-21598, 1993.

O. Zegarra-moran, L. J. Galietta, and . Cftr, Cell Mol Life Sci, 2016.

N. Pedemonte, G. L. Lukacs, K. Du, E. Caci, O. Zegarra-moran et al., Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening, J Clin Invest, vol.115, pp.2564-2571, 2005.

C. Norez, S. Noel, M. Wilke, M. Bijvelds, H. Jorna et al., Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells by the alpha-glucosidase inhibitor miglustat, FEBS Lett, 2006.

, , vol.580, pp.2081-2086

R. Robert, G. W. Carlile, J. Liao, H. Balghi, P. Lesimple et al., Correction of the phe508 cystic fibrosis transmembrane conductance regulator trafficking defect by the bioavailable compound glafenine, Mol Pharmacol, vol.77, pp.922-930, 2010.

G. W. Carlile, R. A. Keyzers, K. A. Teske, R. Robert, D. E. Williams et al., Correction of F508del-CFTR trafficking by the sponge alkaloid latonduine is modulated by interaction with PARP, Chem Biol, vol.19, pp.1288-1299, 2012.

F. Van-goor, S. Hadida, P. D. Grootenhuis, B. Burton, J. H. Stack et al., Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809, Proc Natl Acad Sci, vol.108, pp.18843-18848, 2011.

J. P. Clancy, S. M. Rowe, F. J. Accurso, M. L. Aitken, R. S. Amin et al., Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation, Thorax, vol.67, pp.12-18, 2012.

D. M. Cholon, N. L. Quinney, M. L. Fulcher, C. R. Esther, J. Das et al., Potentiator ivacaftor abrogates pharmacological correction of delF508 CFTR in cystic fibrosis, Sci Transl Med, vol.6, pp.246-96, 2014.

N. Benz, L. Hir, S. Norez, C. Kerbiriou, M. Calvez et al., Improvement of Chloride Transport Defect by Gonadotropin-Releasing Hormone (GnRH) in Cystic Fibrosis Epithelial Cells, PLoSONE, vol.9, issue.2, p.88964, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00990343

D. Adam, J. Roux-delrieu, E. Luczka, A. Bonnomet, J. Lesage et al., Cystic fibrosis airway epithelium remodelling: involvement of inflammation, J Pathol, vol.235, issue.3, pp.408-419, 2015.

C. Farre, S. Stoelzle, C. Haarmann, M. George, and A. Brüggemann, Automated ion channel screening: patch clamping made easy, Expert Opin Ther Targets, vol.11, issue.4, pp.557-565, 2007.

A. Lemay, N. Faure, and F. Labrie, Sensitivity of pituitary and corpus luteum responses to single intranasal administration of (D-ser[TBU]6-des-gly-NH2(10)) luteinizing hormone-releasing hormone ethylamide (Buserelin) in normal women, Fertil Steril, vol.37, issue.2, pp.193-200, 1982.

S. S. Kakar and L. Jennes, Expression of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor mRNAs in various non-reproductive human tissues, Cancer Lett, vol.98, issue.1, pp.57-62, 1995.

A. Tieva, P. Stattin, P. Wikström, A. Bergh, and J. E. Damber, Gonadotropin-releasing hormone receptor expression in the human prostate, Prostate, vol.47, issue.4, pp.276-284, 2001.

K. Koushik, N. Bandi, S. Sundaram, and U. B. Kompella, Evidence for LHRH-Receptor Expression in Human Airway Epithelial (Calu-3) Cells and Its Role in the Transport of a LHRH Agonist, Pharmaceutical Research, vol.21, issue.6, pp.1034-1046, 2004.

B. Illek, R. Maurisse, L. Wahler, K. Kunzelmann, H. Fischer et al., Cl transport in complemented CF bronchial epithelial cells correlates with CFTR mRNA expression levels, Cell. Physiol. Biochem, vol.22, pp.57-68, 2008.

S. H. Bernacki, A. L. Nelson, L. Abdullah, J. K. Sheehan, A. Harris et al., Mucin gene expression during differentiation of human airway epithelia in vitro. Muc4 and muc5b are strongly induced, Am J Respir Cell Mol Biol, vol.20, issue.4, pp.595-604, 1999.

C. W. Scott and M. F. Peters, Label-free whole-cell assays: expanding the scope of GPCR screening, Drug. Discov. Today, vol.15, pp.704-716, 2010.

I. Nederpelt, R. D. Vergroesen, A. P. Ijzerman, and L. H. Heitman, Persistent GnRH receptor activation in pituitary ?T3-1 cells analyzed with a label-free technology, Biosens Bioelectron, vol.15, issue.79, pp.721-727, 2016.

I. Nederpelt, V. Georgi, F. Schiele, K. Nowak-reppel, A. E. Fernandez-montalvan et al., Characterization of 12 GnRH peptide agonists-a kinetic perspective, J. Pharmacol, vol.173, pp.128-141, 2015.

I. Nederpelt, V. Georgi, F. Schiele, K. Nowak-reppel, A. E. Fernández-montalván et al., Characterization of 12 GnRH peptide agonists-a kinetic perspective, Br J Pharmacol, vol.173, issue.1, pp.128-169, 2016.

U. Kertscher, M. Brudel, B. Mehlis, J. Sandow, and H. Berger, Pathways of degradation of buserelin by rat kidney membrane, Journal of Pharmacology and Experimental Therapeutics, vol.273, issue.2, pp.709-715, 1995.

R. M. Perrett and C. A. Mcardle, Molecular Mechanisms of Gonadotropin-Releasing Hormone Signaling: Integrating Cyclic Nucleotides into the Network, Front Endocrinol, vol.4, p.180, 2013.

D. C. Gadsby and A. C. Nairn, Control of CFTR channel gating by phosphorylation and nucleotide hydrolysis, Physiol. Rev, vol.79, pp.77-107, 1999.

Z. Bozoky, S. Ahmadi, T. Milman, T. H. Kim, K. Du et al., Synergy of cAMP and calcium signaling pathways in CFTR regulation, Proc Natl Acad Sci, vol.114, issue.11, pp.2086-2095, 2017.

P. G. Gettins, Serpin structure, mechanism, and function, Chem Rev, vol.102, issue.12, pp.4751-4804, 2002.

G. A. Silverman, J. C. Whisstock, S. P. Bottomley, J. A. Huntington, D. Kaiserman et al., Serpins flex their muscle: I. Putting the clamps on proteolysis in diverse biological systems, J Biol Chem, 2010.

, , vol.285, pp.24299-24305

F. Ciscato, M. Sciacovelli, G. Villano, C. Turato, P. Bernardi et al., SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I, vol.5, pp.2418-2427, 2014.

Y. Sun, N. Sheshadri, and W. X. Zong, SERPINB3 and B4: From biochemistry to biology, Semin Cell Dev Biol, vol.62, pp.170-177, 2017.

F. Lunardi, G. Villano, E. Perissinotto, C. Agostini, F. Rea et al., Overexpression of SERPIN B3 promotes epithelial proliferation and lung fibrosis in mice, Lab Invest, vol.91, issue.6, pp.945-54, 2011.

F. Calabrese, F. Lunardi, C. Giacometti, G. Marulli, M. Gnoato et al., Overexpression of squamous cell carcinoma antigen in idiopathic pulmonary fibrosis: clinicopathological correlations, Thorax, vol.63, issue.9, pp.795-802, 2008.

A. G. Valdivieso, M. Clauzure, M. C. Marín, G. L. Taminelli, M. Copiz et al., The mitochondrial complex I activity is reduced in cells with impaired cystic fibrosis transmembrane conductance regulator (CFTR) function, PLoSOne, vol.7, issue.11, p.48059, 2012.

S. Naghdi and G. Hajnóczky, VDAC2-specific cellular functions and the underlying structure, BBA-Molecular Cell Research, vol.1863, pp.2503-2514, 2016.

A. G. Valdivieso and T. A. Santa-coloma, CFTR activity and mitochondrial function, Redox Biol, vol.1, pp.190-202, 2013.

A. Atlante, M. Favia, A. Bobba, L. Guerra, V. Casavola et al., Characterization of mitochondrial function in cells with impaired cystic fibrosis transmembrane conductance regulator (CFTR) function, J Bioenerg Biomembr, vol.48, issue.3, p.27146408, 2016.

M. D. Amaral, CFTR and chaperones: processing and degradation, J Mol Neurosci, vol.23, pp.41-48, 2004.

O. V. Singh, H. B. Pollard, and P. L. Zeitlin, Chemical Rescue of ?F508-CFTR Mimics Genetic Repair in Cystic Fibrosis Bronchial Epithelial, Cells Mol Cell Proteomics, vol.7, issue.6, pp.1099-1110, 2008.

L. Jeanson, C. Guerrera, I. Papon, J. F. Chhuon, C. Zadigue et al., Proteomic Analysis of Nasal Epithelial Cells from Cystic Fibrosis Patients, PLoSONE, vol.9, issue.9, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01361837

S. Pankow, C. Bamberger, D. Calzolari, S. Martínez-bartolomé, M. Lavallée-adam et al., ?F508 CFTR interactome remodelling promotes rescue of cystic fibrosis, Nature, vol.528, issue.7583, pp.510-516, 2015.

Q. Weia, G. Zhua, X. Cuia, L. Kanga, D. Caoc et al., Expression of CCT6A mRNA in chicken granulosa cells is regulated by progesterone, General and Comparative Endocrinology, vol.189, pp.15-23, 2013.

V. Thulasiraman, C. F. Yang, and J. Frydman, In vivo newly translated polypeptides are sequestered in a protected folding environment, EMBO J, vol.18, pp.85-95, 1999.

H. Sternlicht, G. W. Farr, M. L. Sternlicht, J. K. Driscoll, K. Willison et al., The t-complex polypeptide 1 complex is a chaperonin for tubulin and actin in vivo, Proc. Natl. Acad. Sci, vol.90, pp.9422-9426, 1993.

A. R. Finch, C. J. Caunt, S. P. Armstrong, and C. A. Mcardle, Agonist-induced internalization and downregulation of gonadotropin-releasing hormone receptors, Am J Physiol Cell Physiol, vol.297, issue.3, pp.591-600, 2009.

B. Ohlsson, Gonadotropin-Releasing Hormone and Its Physiological and Pathophysiological Roles in Relation to the Structure and Function of the Gastrointestinal Tract, European surgical Research, vol.57, pp.1-2, 2016.

B. Khadivi, T. Peirouvi, M. Z. Javanmard, and Y. Rasmi, Short-term buserelin administration induces apoptosis and morphological changes in adult rat testes, Acta Cir. Bras, vol.32, pp.140-147, 2017.

A. Lemay, R. Maheux, C. Huot, J. Blanchet, and N. Faure, Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis, Am J Obstet Gynecol, vol.158, issue.2, pp.233-239, 1988.